| N-[(1R)-1-(Hydroxydiphenylmethyl)-3-methylbutyl]-D-prolinamide |
1088110-92-2 |
1088110-92-2 |
| 1-(5-Methoxy-2-Methyl-4-nitrophenyl)-N,N-diMethylpiperidin-4-aMine |
BRIGATINIB 中间体 |
1089279-90-2 |
| N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-3-(5-isopropoxy-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridin-5-amine |
N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-3-(5-isopropoxy-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridin-5-amine |
1079274-94-4 |
| BMS-819881 |
1197420-05-5 |
1197420-05-5 |
| 2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile |
BARICITINIB中间体 |
1187594-13-3 |
| 1H-Indole-2-acetic acid, 6-fluoro-alpha,alpha-diMethyl-5-nitro-, phenylMethyl ester |
BENZYL 2-(6-FLUORO-5-NITRO-1H-INDOL-2-YL)-2-METHYLPROPANOATE |
1152311-77-7 |
| 1-(Tetrahydropyran-2-yl)pyrazole-5-boronic acid |
1-(TETRAHYDROPYRAN-2-YL)PYRAZOLE-5-BORONIC ACID |
1105511-68-9 |
| Ipatasertib intermediate |
Ipatasertib intermediate |
1001269-85-7 |
| GSK1292263 |
GSK1292263 |
1032823-75-8 |
| 2-(2-Cyano-vinylaMino)-Malonicaciddiethylester |
1021175-71-2 |
1021175-71-2 |
| N-BOC-3-BROMO-4-HYDROXY-PYRROLIDINE |
N-BOC-3-溴-4-羟基吡咯烷 |
1017782-17-0 |
| (R)-(+)-2-Methyl-2-propanesulfinamide |
(R)-(+)-叔丁基亚磺酰胺 |
196929-78-9 |
| 4-Isopropoxyethoxymethylphenol |
4-异丙氧基乙氧基甲基酚 |
177034-57-0 |
| 1-CHLORO-4-(4-METHYLTHIOPHEN-2-YL)PHTHALAZINE |
1-CHLORO-4-(4-METHYLTHIOPHEN-2-YL)PHTHALAZINE |
149549-12-2 |
| Goralatide |
戈雷拉肽 |
120081-14-3 |
| Dapoxetine |
达泊西汀 |
119356-77-3 |
| METHYL (2S)-GLYCIDATE |
甲基(S)-环氧乙烷羧酸 |
118712-39-3 |
| 2,4-Dichloro-7,8-dihydro-5H-pyrano[4,3-d]pyriMidine |
2,4-二氯-7,8-二氢-5H-吡喃并[4,3-D]嘧啶 |
944902-88-9 |
| PF-03814735 |
N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺 |
942487-16-3 |
| (1H-Pyrrolo[2,3-b]pyridin-3-yl)methanamine |
(1H-吡咯并[2,3-B]吡啶-3-基)甲胺 |
933691-80-6 |
